Does osteoprotegerin affect the responsiveness of fibroblast growth factor-23 to high oral phosphate intake?
Therefore, OPG may play a key role in mediating the response of FGF-23 to an oral phosphate load in bone cells.
The results imply that expression of IL-10 is a prognostic factor in patients with NPC and may prove valuable in selecting patients with NPC who are candidates for aggressive therapy.